Calcium entry blockers in cardiovascular and cerebral dysfunctions:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Boston u.a.
Nijhoff
1984
|
| Schriftenreihe: | Developments in cardiovascular medicine
40 |
| Schlagworte: | |
| Beschreibung: | 322 S. Ill. |
| ISBN: | 0898386586 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV000167428 | ||
| 003 | DE-604 | ||
| 005 | 20091215 | ||
| 007 | t | ||
| 008 | 870612s1984 a||| |||| 00||| eng d | ||
| 020 | |a 0898386586 |9 0-89838-658-6 | ||
| 035 | |a (OCoLC)10725617 | ||
| 035 | |a (DE-599)BVBBV000167428 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-355 |a DE-188 | ||
| 050 | 0 | |a RC684.C34 | |
| 082 | 0 | |a 616.1/061 |2 19 | |
| 084 | |a VS 8100 |0 (DE-625)147711:253 |2 rvk | ||
| 084 | |a MED 920f |2 stub | ||
| 084 | |a MED 604f |2 stub | ||
| 084 | |a MED 410f |2 stub | ||
| 245 | 1 | 0 | |a Calcium entry blockers in cardiovascular and cerebral dysfunctions |c ed. by Théophile Godfraind ... |
| 264 | 1 | |a Boston u.a. |b Nijhoff |c 1984 | |
| 300 | |a 322 S. |b Ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Developments in cardiovascular medicine |v 40 | |
| 650 | 2 | |a Angiopathies intracrâniennes - traitement médicamenteux | |
| 650 | 2 | |a Hypertension artérielle - traitement médicamenteux | |
| 650 | 2 | |a Inhibiteurs des canaux calciques | |
| 650 | 2 | |a Maladies cardiovasculaires - traitement médicamenteux | |
| 650 | 4 | |a Calcium Channel Blockers |x pharmacology | |
| 650 | 4 | |a Calcium Channel Blockers |x therapeutic use | |
| 650 | 4 | |a Calcium |x Antagonists |x Therapeutic use | |
| 650 | 4 | |a Cardiovascular Diseases |x drug therapy | |
| 650 | 4 | |a Cardiovascular system |x Diseases |x Chemotherapy | |
| 650 | 4 | |a Cerebrovascular Disorders |x drug therapy | |
| 650 | 4 | |a Cerebrovascular disease |x Chemotherapy | |
| 650 | 4 | |a Hypertension |x drug therapy | |
| 650 | 0 | 7 | |a Chemotherapie |0 (DE-588)4127083-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hirngefäßkrankheit |0 (DE-588)4025015-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kreislaufmittel |0 (DE-588)4163325-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Calciumantagonist |0 (DE-588)4069807-5 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Calciumantagonist |0 (DE-588)4069807-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Hirngefäßkrankheit |0 (DE-588)4025015-5 |D s |
| 689 | 1 | 1 | |a Chemotherapie |0 (DE-588)4127083-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Kreislaufmittel |0 (DE-588)4163325-8 |D s |
| 689 | 2 | |5 DE-604 | |
| 700 | 1 | |a Godfraind, Théophile |e Sonstige |4 oth | |
| 830 | 0 | |a Developments in cardiovascular medicine |v 40 |w (DE-604)BV000000660 |9 40 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000095208 | ||
Datensatz im Suchindex
| _version_ | 1804114626715058176 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV000167428 |
| callnumber-first | R - Medicine |
| callnumber-label | RC684 |
| callnumber-raw | RC684.C34 |
| callnumber-search | RC684.C34 |
| callnumber-sort | RC 3684 C34 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | VS 8100 |
| classification_tum | MED 920f MED 604f MED 410f |
| ctrlnum | (OCoLC)10725617 (DE-599)BVBBV000167428 |
| dewey-full | 616.1/061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.1/061 |
| dewey-search | 616.1/061 |
| dewey-sort | 3616.1 261 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02422nam a2200637 cb4500</leader><controlfield tag="001">BV000167428</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20091215 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">870612s1984 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0898386586</subfield><subfield code="9">0-89838-658-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)10725617</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000167428</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC684.C34</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.1/061</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 8100</subfield><subfield code="0">(DE-625)147711:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 920f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 604f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 410f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Calcium entry blockers in cardiovascular and cerebral dysfunctions</subfield><subfield code="c">ed. by Théophile Godfraind ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston u.a.</subfield><subfield code="b">Nijhoff</subfield><subfield code="c">1984</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">322 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Developments in cardiovascular medicine</subfield><subfield code="v">40</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Angiopathies intracrâniennes - traitement médicamenteux</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Hypertension artérielle - traitement médicamenteux</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Inhibiteurs des canaux calciques</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Maladies cardiovasculaires - traitement médicamenteux</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Calcium Channel Blockers</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Calcium Channel Blockers</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Calcium</subfield><subfield code="x">Antagonists</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Diseases</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular system</subfield><subfield code="x">Diseases</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cerebrovascular Disorders</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cerebrovascular disease</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hypertension</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hirngefäßkrankheit</subfield><subfield code="0">(DE-588)4025015-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kreislaufmittel</subfield><subfield code="0">(DE-588)4163325-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Calciumantagonist</subfield><subfield code="0">(DE-588)4069807-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Calciumantagonist</subfield><subfield code="0">(DE-588)4069807-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Hirngefäßkrankheit</subfield><subfield code="0">(DE-588)4025015-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Kreislaufmittel</subfield><subfield code="0">(DE-588)4163325-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Godfraind, Théophile</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Developments in cardiovascular medicine</subfield><subfield code="v">40</subfield><subfield code="w">(DE-604)BV000000660</subfield><subfield code="9">40</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000095208</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV000167428 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T15:09:43Z |
| institution | BVB |
| isbn | 0898386586 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000095208 |
| oclc_num | 10725617 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR DE-188 |
| owner_facet | DE-12 DE-355 DE-BY-UBR DE-188 |
| physical | 322 S. Ill. |
| publishDate | 1984 |
| publishDateSearch | 1984 |
| publishDateSort | 1984 |
| publisher | Nijhoff |
| record_format | marc |
| series | Developments in cardiovascular medicine |
| series2 | Developments in cardiovascular medicine |
| spelling | Calcium entry blockers in cardiovascular and cerebral dysfunctions ed. by Théophile Godfraind ... Boston u.a. Nijhoff 1984 322 S. Ill. txt rdacontent n rdamedia nc rdacarrier Developments in cardiovascular medicine 40 Angiopathies intracrâniennes - traitement médicamenteux Hypertension artérielle - traitement médicamenteux Inhibiteurs des canaux calciques Maladies cardiovasculaires - traitement médicamenteux Calcium Channel Blockers pharmacology Calcium Channel Blockers therapeutic use Calcium Antagonists Therapeutic use Cardiovascular Diseases drug therapy Cardiovascular system Diseases Chemotherapy Cerebrovascular Disorders drug therapy Cerebrovascular disease Chemotherapy Hypertension drug therapy Chemotherapie (DE-588)4127083-6 gnd rswk-swf Hirngefäßkrankheit (DE-588)4025015-5 gnd rswk-swf Kreislaufmittel (DE-588)4163325-8 gnd rswk-swf Calciumantagonist (DE-588)4069807-5 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Calciumantagonist (DE-588)4069807-5 s DE-604 Hirngefäßkrankheit (DE-588)4025015-5 s Chemotherapie (DE-588)4127083-6 s Kreislaufmittel (DE-588)4163325-8 s Godfraind, Théophile Sonstige oth Developments in cardiovascular medicine 40 (DE-604)BV000000660 40 |
| spellingShingle | Calcium entry blockers in cardiovascular and cerebral dysfunctions Developments in cardiovascular medicine Angiopathies intracrâniennes - traitement médicamenteux Hypertension artérielle - traitement médicamenteux Inhibiteurs des canaux calciques Maladies cardiovasculaires - traitement médicamenteux Calcium Channel Blockers pharmacology Calcium Channel Blockers therapeutic use Calcium Antagonists Therapeutic use Cardiovascular Diseases drug therapy Cardiovascular system Diseases Chemotherapy Cerebrovascular Disorders drug therapy Cerebrovascular disease Chemotherapy Hypertension drug therapy Chemotherapie (DE-588)4127083-6 gnd Hirngefäßkrankheit (DE-588)4025015-5 gnd Kreislaufmittel (DE-588)4163325-8 gnd Calciumantagonist (DE-588)4069807-5 gnd |
| subject_GND | (DE-588)4127083-6 (DE-588)4025015-5 (DE-588)4163325-8 (DE-588)4069807-5 (DE-588)4143413-4 |
| title | Calcium entry blockers in cardiovascular and cerebral dysfunctions |
| title_auth | Calcium entry blockers in cardiovascular and cerebral dysfunctions |
| title_exact_search | Calcium entry blockers in cardiovascular and cerebral dysfunctions |
| title_full | Calcium entry blockers in cardiovascular and cerebral dysfunctions ed. by Théophile Godfraind ... |
| title_fullStr | Calcium entry blockers in cardiovascular and cerebral dysfunctions ed. by Théophile Godfraind ... |
| title_full_unstemmed | Calcium entry blockers in cardiovascular and cerebral dysfunctions ed. by Théophile Godfraind ... |
| title_short | Calcium entry blockers in cardiovascular and cerebral dysfunctions |
| title_sort | calcium entry blockers in cardiovascular and cerebral dysfunctions |
| topic | Angiopathies intracrâniennes - traitement médicamenteux Hypertension artérielle - traitement médicamenteux Inhibiteurs des canaux calciques Maladies cardiovasculaires - traitement médicamenteux Calcium Channel Blockers pharmacology Calcium Channel Blockers therapeutic use Calcium Antagonists Therapeutic use Cardiovascular Diseases drug therapy Cardiovascular system Diseases Chemotherapy Cerebrovascular Disorders drug therapy Cerebrovascular disease Chemotherapy Hypertension drug therapy Chemotherapie (DE-588)4127083-6 gnd Hirngefäßkrankheit (DE-588)4025015-5 gnd Kreislaufmittel (DE-588)4163325-8 gnd Calciumantagonist (DE-588)4069807-5 gnd |
| topic_facet | Angiopathies intracrâniennes - traitement médicamenteux Hypertension artérielle - traitement médicamenteux Inhibiteurs des canaux calciques Maladies cardiovasculaires - traitement médicamenteux Calcium Channel Blockers pharmacology Calcium Channel Blockers therapeutic use Calcium Antagonists Therapeutic use Cardiovascular Diseases drug therapy Cardiovascular system Diseases Chemotherapy Cerebrovascular Disorders drug therapy Cerebrovascular disease Chemotherapy Hypertension drug therapy Chemotherapie Hirngefäßkrankheit Kreislaufmittel Calciumantagonist Aufsatzsammlung |
| volume_link | (DE-604)BV000000660 |
| work_keys_str_mv | AT godfraindtheophile calciumentryblockersincardiovascularandcerebraldysfunctions |